导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 37.55% | 92/1050 |
| 近一周 | -1.29% | 172/1104 |
| 近一月 | -5.78% | 687/1102 |
| 近一季 | -7.99% | 580/1092 |
| 近半年 | 26.60% | 97/1070 |
| 近一年 | 40.01% | 111/1018 |
| 近两年 | 110.20% | 162/926 |
| 近三年 | 79.07% | 127/834 |
| 成立以来 | 183.55% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.11% 332/1070 |
77.46% 120/1101 |
- - |
- - |
| 2025 | 26.08% 565/1065 |
0.55% 757/1014 |
-1.27% 795/1038 |
33.46% 309/1050 |
-4.85% 702/1065 |
| 2024 | 4.82% 431/1011 |
-6.91% 653/960 |
1.43% 218/983 |
10.57% 580/991 |
0.39% 296/1011 |
| 2023 | -15.41% 539/952 |
- 634/880 |
-4.76% 507/895 |
-9.23% 557/915 |
-2.16% 244/952 |
| 2022 | -20.18% 329/867 |
-21.94% 636/773 |
9.84% 276/806 |
-0.09% 15/845 |
-6.82% 696/867 |
| 2021 | 6.38% 284/740 |
-11.67% 519/580 |
14.54% 245/659 |
-4.90% 351/704 |
10.57% 71/740 |
| 2020 | 68.35% 148/554 |
2.04% 113/419 |
36.86% 50/466 |
8.69% 280/517 |
10.91% 339/554 |
| 2019 | 41.35% 209/410 |
28.36% 472/1146 |
-6.96% 848/1228 |
5.65% 191/390 |
12.03% 108/410 |
| 2018 | -10.36% 9/349 |
- - |
-6.41% 227/990 |
-3.24% 381/1000 |
-10.15% 308/1080 |
| 2017 | 16.86% 92/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华夏经济转型股票 VS. 东吴新产业精选股票A(580008) |